[OROPHARYS CANCER: THE SQUAMOUS CELL]

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Context:

• Diffuse Large B-Cell Lymphoma (DLBCL) is the most common non-Hodgkin lymphoma.
• The utility of CT/PET scans in initial DLBCL staging remains debated.
• Current evidence suggests limited impact on initial patient management.

Purpose:

• To evaluate the evolving role of CT/PET in DLBCL management.
• To explore the application of CT/PET in assessing treatment response.
• To investigate the potential for CT/PET in risk-adapted therapy strategies.

Summary:

• CT/PET scans have a controversial role in the initial staging of Diffuse Large B-Cell Lymphoma.
• Recent publications and expert consensus highlight the utility of CT/PET for evaluating end-of-treatment response.
• There is growing interest in using CT/PET during treatment for risk-adapted therapy.

Impact:

• This research informs the clinical application of CT/PET in DLBCL.
• It supports a shift towards using CT/PET for response assessment rather than initial staging.
• Findings contribute to the development of personalized treatment strategies for DLBCL patients.